Catalyst
Slingshot members are tracking this event:
FDA delays Nektar Therapeutics' (NKTR) marketing application for NKTR-181 opioid in lower back pain
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NKTR |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 30, 2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nktr-181, Chronic Lower Back Pain
